Oxiracetam

This classification denotes a nutritional supplement and neuroprotective agent with the molecular formula C6H10N2O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier P7U817352G, chemically known as 1-pyrrolidineacetamide, 4-hydroxy-2-oxo-, (s)- but generally known as oxiracetam, which bears US NIH Compound Identifier 4626. European Medicines Agency schedules Oxiracetam in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09536MIG. The term OXIRACETAM is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 34, No. 10 1980, List 20). World Health Organization schedules oxiracetam in its Anatomical Therapeutic Chemical (ATC) Classification. OXIRACETAM is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule oxiracetam under HS 29337900 and SITC 51561. As of Q4 2014, OXIRACETAM remains the US FDA Preferred Term for this commodity. Oxiracetam bears US NLM identifiers UMLS ID C0069772 and NCI Concept Code C66271. SMILES: OC1CN(C(=O)C1)CC(=O)N.